Published in

Elsevier, Human Pathology, 10(45), p. 2162-2167, 2014

DOI: 10.1016/j.humpath.2014.05.019

Links

Tools

Export citation

Search in Google Scholar

A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Lynch syndrome is caused by germline mutations in one of the four DNA mismatch repair genes (MLH1, MSH2, MSH6 and PMS2). Mutations in MSH2 cause concomitant loss of hMSH6, while MLH1 mutations lead to concurrent loss of PMS2. Much less frequent mutations in MSH6 or PMS2 are associated with the isolated loss of the corresponding proteins. We here demonstrate the causative role of the first germline mutation of MSH2, c.1249-1251 dupGTT (p.417 V-418I dupV), associated with normal hMSH2 expression and lack of hMSH6 protein despite a normal MSH6 gene sequence. hMSH6 protein was completely lost only in advanced cancer stages due to two different “second hits,” a whole MSH2 gene deletion and a frame-shifting insertion in the MSH6 (C)8 repeat in the coding sequence.